185 related articles for article (PubMed ID: 12433643)
1. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
Huang W; Gong FY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
3. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
5. [Study on the influence factors of the serum fibrosis markers].
Cai WM; Tao J; Weng HL; Liu RH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):23-5. PubMed ID: 12546736
[TBL] [Abstract][Full Text] [Related]
6. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
7. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
9. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
10. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
12. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
13. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
[TBL] [Abstract][Full Text] [Related]
15. Assessing routine and serum markers of liver fibrosis in CHB patients using parallel and serial interpretation.
Hongbo L; Xiaohui L; Hong K; Wei W; Yong Z
Clin Biochem; 2007 May; 40(8):562-6. PubMed ID: 17362902
[TBL] [Abstract][Full Text] [Related]
16. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
17. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
18. [Serum gamma-glutamyl transpeptidase activity in children with chronic hepatitis B].
Lebensztejn DM; Skiba E; Sobaniec-Lotowska ME; Kaczmarski M
Pol Merkur Lekarski; 2005 Mar; 18(105):271-4. PubMed ID: 15997630
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.
Mohamadnejad M; Montazeri G; Fazlollahi A; Zamani F; Nasiri J; Nobakht H; Forouzanfar MH; Abedian S; Tavangar SM; Mohamadkhani A; Ghoujeghi F; Estakhri A; Nouri N; Farzadi Z; Najjari A; Malekzadeh R
Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
Islam S; Antonsson L; Westin J; Lagging M
Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
